Trending
- FDA approves Rasonque, pancreatic cancer drug expected to extend lives
- CELMoD Wins “Landmark Approval” in Relapsed/Refractory Multiple Myeloma
- Venetoclax/HMA Combo Demonstrates Real-World Efficacy in Unfit AML
- All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
- Debate: Class Effect Versus Meaningful Differences Among BCMA Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
- Exploring The Future of Radiopharmaceutical Therapy in Oncology
- Radiation link in flight attendant’s breast cancer, French court finds
- Explainable artificial intelligence reveals key surgical parameters in robot-assisted and open radical prostatectomy
Wednesday, August 26